Under way, not recruiting
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
NCT06434649 · Ning Xu · Updated 13 April 2026
- What is being tested
- Extrafascial robotic assisted radical prostatectomy via posterior approach; Extrafascial robotic assisted radical prostatectomy via anterior approach
- For
- Surgical Procedure, Unspecified; Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 118 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Nov 2025, ends 31 Dec 2026. Registered 30 May 2024.
- Results
- None posted yet.
In the researchers' words
This study was designed as a prospective, multicentre, double-blind, randomised controlled clinical trial. It aims to investigate the feasibility and safety of the posterior approach extrafascial technique and the anterior approach extrafascial technique in robot-assisted radical prostatectomy (RARP) for intermediate- and high-risk prostate cancer patients, to compare the oncological prognosis, functional prognosis, and safety of the two techniques in intermediate- and high-risk prostate cancer patients, and to provide evidence-based medical evidence for the choice of surgical treatment modality for intermediate- and high-risk prostate cancer patients.
Sites
- first hospital affiliated of Fujian medical universityFuzhou, Fujian, China